John Wesolowski
Principal Accounting Officer & ControllerMr. John Wesolowski, C.P.A., M.B.A., serves as the Principal Accounting Officer and Controller of Intensity Therapeutics, Inc since March 2017 and served as its Interim Chief Financial Officer since June 20, 2023 until December 2023. Prior to joining Intensity Therapeutics, Inc., from 1998 to 2016, Mr. Wesolowski was Director of Costing in the Yale University Controller’s office. In that role he conducted financial reporting, property tax management, was responsible for calculations of overhead and benefit rates, and was involved in numerous special projects related to accounting process and controls. Also at Yale, he was involved in financial reporting and the accounting matters related to clinical trials and other organized research. Prior to joining Yale Mr. Wesolowski was the Vice President and Controller for Automatic Fastener Corporation in Branford, CT from 1988 to 1998. In this role, he oversaw all accounting, purchasing and human resource functions. Mr. Wesolowski also has experience in public accounting and auditing from working at KMG Main Hurdman, now KPMG. He is a Certified Public Account since 1983. Mr. Wesolowski received an M.B.A from the University of Connecticut in Management Science and a Bachelor of Science in Finance from The Pennsylvania State University (Penn State at University Park).
Positions
- Company NameIntensity Therapeutics, Inc.Stock CodeINTSPositionPrincipal Accounting Officer & ControllerColleagues
- LHLewis H. BenderFounder, President, CEO & Chairman of the Board
- JTJoseph TalamoChief Financial Officer
- JMJames M. AhlersExecutive Vice President of Corporate Finance
- ELEmer LeahyIndependent Director
- MAMark A. GoldbergIndependent Director
- DJDaniel J. DonovanIndependent Director
- RLRiccardo LencioniMember of Scientific Advisory Board
